Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: BioPharma Catalyst Trade Pick Of The Week: Biodel

We get a mention...

"With all the buzz associated with Mannkind (MNKD) lately surrounding its Phase III Diabetes inhaler Afrezza, Biodel seems poised to take advantage of it as both companies are seeking to offer treatments in the same segment."

http://seekingalpha.com/article/1581942-biopharma-catalyst-trade-pick-of-the-week-biodel?source=google_news

Share
New Message
Please login to post a reply